In the rat model, 6-hydroxydopamine (6-OHDA) known as a selective catecholaminergic neurotoxin used chiefly in modeling Parkinson's disease (PD). Continuous aerobic exercise and curcumin supplementations could play a vital role in neuroprotection. This study aimed to explore the neuroprotective roles of regular aerobic exercise and curcumin during PD. For this, rats were treated as follows for 8 consecutive weeks (5 d in a week): For this, animals were orally treated with curcumin (50 ml/kg) alone or in combination with aerobic exercise. Compared with a control group, induction of PD by 6-OHDA increased the amount of alpha-synuclein protein and malondialdehyde levels and decreased the number of substantia nigra neurons, total antioxidant capacity, and glutathione peroxidase activity in brain tissue. All these changes were abolished by the administration of curcumin with aerobic exercise treatments. Activity behavioral tests also confirmed the above-mentioned results by increasing the rod test time and the number of rotations due to apomorphine injection. Histopathology assays mimic the antioxidant activity and behavioral observations. Combined curcumin with aerobic exercise treatments is potentially an effective strategy for modifying the dopaminergic neuron dysfunction in 6-OHDA-induced rats modeling PD via dual inhibiting oxidative stress indices and regulating behavioral tasks.

Faculty of Veterinary Medicine Tabriz Medical Science Islamic Azad University Tabriz Iran

Zobrazit více v PubMed

Willis AW, Evanoff BA, Lian M, Criswell SR, Racette BA. Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries. Neuroepidemiol. 2010;34(3):143–151. doi: 10.1159/000275491. PubMed DOI PMC

Tysnes O, Storstein A. Epidemiology of Parkinson’s disease. J Neural Transm (Vienna) 2017;124(8):901–905. doi: 10.1007/s00702-017-1686-y. PubMed DOI

Johns Hopkins Medicine. Parkinson’s Disease. 2022. https://www.hopkinsmedicine.org/health/conditions-and-diseases/parkinsons-disease .

Balestrino R, Schapira A. Parkinson disease. Eur J Neurol. 2020;27(1):27–42. doi: 10.1111/ene.14108. PubMed DOI

Colpo GD, Ribeiro FM, Rocha NP, Teixeira AL. Animal models for the study of human neurodegenerative diseases. Anim Models Hum Dis. 2017:1109–29. doi: 10.1016/B978-0-12-809468-6.00042-5. DOI

Proukakis C, Houlden H, Schapira AH. Somatic alpha-synuclein mutations in Parkinson’s disease: Hypothesis and preliminary data. Mov Disord. 2013;28(6):705–12. doi: 10.1002/mds.25502. PubMed DOI PMC

Fujita H, Ogino T, Kobuchi H, Fujiwara T, Yano H, Akiyama J, Utsumi K, Sasaki J. Cell-permeable cAMP analog suppresses 6-hydroxyDA-induced apoptosis in PC12 cells through the activation of the Akt pathway. Brain Res. 2006;1113:10. doi: 10.1016/j.brainres.2006.06.079. PubMed DOI

Kaczyńska K, Andrzejewski K. Genetics, neurology, behavior, and diet in Parkinson’s disease. Chapter 40 - 6-hydroxydopamine-induced model of Parkinson’s disease. The Neurosci Parkinson’s. 2020;2:627–642. doi: 10.1016/B978-0-12-815950-7.00040-0. DOI

Ewald B, Sampath D, Plunkett W. H2AX phosphorylation marks gemcitabine-induced stalled replication forks and their collapse upon S-phase checkpoint abrogation. Mol Cancer Ther. 2007;6(4):1239–48. doi: 10.1158/1535-7163.MCT-06-0633. PubMed DOI

Fiorini C, Cordani M, Padroni C, Blandino G, Di Agostino S, Donadelli M. Mutant p53 stimulates chemoresistance of pancreatic adenocarcinoma cells to gemcitabine. Biochim et Biophys Acta. 2015;1853(1):89–100. doi: 10.1016/j.bbamcr.2014.10.003. PubMed DOI

Pari L, Murugan P. Effect of tetrahydrocurcumin on blood glucose, plasma insulin and hepatic key enzymes in streptozotocin induced diabetic rats. J Basic Clin Physiol Pharmacol. 2015;16(4):257–274. doi: 10.1515/JBCPP.2005.16.4.257. PubMed DOI

Pari L, Murugan P. Antihyperlipidemic effect of curcumin and tetrahydrocurcumin in experimental type 2 diabetic rats. Ren Fail. 2007;29(7):881–889. doi: 10.1080/08860220701540326. PubMed DOI

Pan J, Li H, Ma J-F, Tan Y-Y, Xiao Q, Ding J-Q, et al. Curcumin inhibition of JNKs prevents dopaminergic neuronal loss in a mouse model of Parkinson’s disease through suppressing mitochondria dysfunction. Transl Neurodegener. 2012;1(1):1–9. doi: 10.1186/2047-9158-1-16. PubMed DOI PMC

Strong R, Miller RA, Astle CM, Baur JA, De Cabo R, Fernandez E, et al. Evaluation of resveratrol, green tea extract, curcumin, oxaloacetic acid, and medium-chain triglyceride oil on life span of genetically heterogeneous mice. J Gerontol Series A: Biomed Sci Med Sci. 2013;68(1):6–16. doi: 10.1093/gerona/gls070. PubMed DOI PMC

John MK, Xie H, Bell EC, Liang D. Development and pharmacokinetic evaluation of a curcumin co-solvent formulation. Anticancer Res. 2013;33(10):4285–91. PubMed

Camiletti-Moirón D, Aparicio V, Aranda P, Radak Z. Does exercise reduce brain oxidative stress? A systematic review. Scand J Med Sci Sports. 2013;23(4):e202–e12. doi: 10.1111/sms.12065. PubMed DOI

Yau SY, Gil-Mohapel J, Christie BR, So KF. Physical exercise-induced adult neurogenesis: a good strategy to prevent cognitive decline in neurodegenerative diseases? BioMed Res Int. 2014:2014. doi: 10.1155/2014/403120. PubMed DOI PMC

Roghani M, Behzadi G, Baluchnejadmojarad T. Efficacy of elevated body swing test in the early model of Parkinson’s disease in rat. Physiol Behav. 2002;76(4–5):507–10. doi: 10.1016/S0031-9384(02)00753-9. PubMed DOI

Tajiri N, Takao Y, Tetsuro S, Akihiko K, Wenji Y, Tomohito K, Feifei W, et al. Exercise exerts neuroprotective effects on Parkinson’s disease model of rats. Brain Res. 2010;1310:200–207. doi: 10.1016/j.brainres.2009.10.075. PubMed DOI

Dursun I, Jakubowskadogru E, Uzbay T. Effects of prenatal exposure to alcohol on activity, anxiety, motor coordination, and memory in young adult Wistar rats. Pharmacol Biochem Behav. 2006;85(2):345–55. doi: 10.1016/j.pbb.2006.09.001. PubMed DOI

Giralt A, Ana S, Olga C, Xavier X, Jordi A, Esther P. Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington’s disease. Hum Mol Genet. 2011;20(21):4232–47. doi: 10.1093/hmg/ddr351. PubMed DOI

Ozdemir E, Cetinkaya S, Ersan S, Kucukosman S, Ersan EE. Serum selenium and plasma malondialdehyde levels and antioxidant enzyme activities in patients with obsessive-compulsive disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2009;33(1):62–5. doi: 10.1016/j.pnpbp.2008.10.004. PubMed DOI

Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem. 2004;37(4):277–85. doi: 10.1016/j.clinbiochem.2003.11.015. PubMed DOI

Lehmensiek V, Tan EM, Liebau S, Lenk T, Zettlmeisl H, Schwarz J, Storch A. Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson’s disease. Neurochem Int. 2006;48(5):329–40. doi: 10.1016/j.neuint.2005.11.008. PubMed DOI

Nguyen TT, Vuu MD, Huynh MA, Yamaguchi M, Tran LT, Dang TPT. Curcumin effectively rescued Parkinson’s disease-like phenotypes in a novel drosophila melanogaster model with dUCH knockdown. Oxid Med Cell Longev. 2018:2018. doi: 10.1155/2018/2038267. PubMed DOI PMC

Nebrisi EE. Neuroprotective Activities of Curcumin in Parkinson’s Disease: A Review of the Literature. Int J Mol Sci. 2021;22(20):11248. doi: 10.3390/ijms222011248. PubMed DOI PMC

Benameur T, Giacomucci G, Panaro MA, Ruggiero M, Trotta T, Monda V, Pizzolorusso I, Lofrumento DD, Porro C, Messina G. New Promising Therapeutic Avenues of Curcumin in Brain Diseases. Mol. 2021;27:236. doi: 10.3390/molecules27010236. PubMed DOI PMC

Trujillo J, Irasema Chirino Y, Molina-Jijón E, CristinaAndérica-Romero A, Tapia E, Pedraza-Chaverrí J. Renoprotective effect of the antioxidant curcumin: Recent findings. Redox Biol. 2013;1(1):448–456. doi: 10.1016/j.redox.2013.09.003. PubMed DOI PMC

Lin X, Bai D, Wei Z, Zhang Y, Huang Y, Deng H, Huang X. Curcumin attenuates oxidative stress in RAW264.7 cells by increasing the activity of antioxidant enzymes and activating the Nrf2-Keap1 pathway. PLoS One. 2019;14(5):e0216711. doi: 10.1371/journal.pone.0216711. PubMed DOI PMC

Dohare P, Garg P, Jain V, Nath C, Ray M. Dose dependence and therapeutic window for the neuroprotective effects of curcumin in thromboembolic model of rat. Behav Brain Res. 2008;193(2):289–97. doi: 10.1016/j.bbr.2008.06.012. PubMed DOI

Bishnoi M, Chopra K, Kulkarni SK. Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain. Pharmacol Biochem Behav. 2008;88(4):511–22. doi: 10.1016/j.pbb.2007.10.009. PubMed DOI

Heebkaew N, Rujanapun N, Kunhorm P, Jaroonwitchawan T, Chaicharoenaudomrung N, Promjantuek W, Noisa P. Curcumin induces neural differentiation of human pluripotent embryonal carcinoma cells through the activation of autophagy. BioMed Res Int. 2019:2019. doi: 10.1155/2019/4378710. PubMed DOI PMC

Bollimpelli VS, Kumar P, Kumari S, Kondapi AK. Neuroprotective effect of curcumin-loaded lactoferrin nano particles against rotenone induced neurotoxicity. Neurochem Int. 2016;95:37–45. doi: 10.1016/j.neuint.2016.01.006. PubMed DOI

Jha N, Jurma O, Lalli G, Liu Y, Pettus EH, Greenamyre JT, et al. Glutathione Depletion in PC12 Results in Selective Inhibition of Mitochondrial Complex I Activity: Iimplications for Parkinson’s For Disease. J Biol Chem. 2000;275(34):26096–101. doi: 10.1074/jbc.M000120200. PubMed DOI

Thiyagarajan M, Sharma SS. Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sci. 2004;74(8):969–85. doi: 10.1016/j.lfs.2003.06.042. PubMed DOI

Ishrat T, Hoda MN, Khan MB, Yousuf S, Ahmad M, Khan MM, et al. Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer’s type (SDAT) Eur Neuropsychopharmacol. 2009;19(9):636–47. doi: 10.1016/j.euroneuro.2009.02.002. PubMed DOI

Monteiro RS, Junior, Cevada T, Oliveira BR, Lattari E, Portugal EM, Carvalho A, et al. We need to move more: Neurobiological hypotheses of physical exercise as a treatment for Parkinson’s disease. Med Hypotheses. 2015;85(5):537. doi: 10.1016/j.mehy.2015.07.011. PubMed DOI

Nebrisi EE, Javed H, Ojha SK, Oz M, Shehab S. Neuroprotective effect of curcumin on the nigrostriatal pathway in a 6-hydroxydopmine-induced rat model of Parkinson’s disease is mediated by α_7-nicotinic receptors. Int J Mol Sci. 2020;21:7329. doi: 10.3390/ijms21197329. PubMed DOI PMC

Olfati A, Tvrda E. Riboflavin recovery of spermatogenic dysfunction via a dual inhibition of oxidative changes and regulation of the PINK1-mediated pathway in arsenic-injured rat model. Physiol Res. 2021;70:591–603. doi: 10.33549/physiolres.934658. PubMed DOI PMC

Olfati A, Moghaddam G, Baradaran B, Hamidian G. The effect of estradiol benzoate and FSH on hormonal levels and stereology structure of testis in Ghezel lambs treated with Tamoxifen citrate. Rev Med Vet. 2018;169(1):58–64.

Investigating the Effect of an Anti-Inflammatory Drug in Determining NURR1 Expression and Thus Exploring the Progression of Parkinson's Disease